Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy
Title:
Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy
Author:
Blackwell, K. Semiglazov, V. Krasnozhon, D. Davidenko, I. Nelyubina, L. Nakov, R. Stiegler, G. Singh, P. Schwebig, A. Kramer, S. Harbeck, N.